Pharmafile Logo
Pharmafocus logo
Advanced Search

Ablynx

Showing 4 posts of 19 posts found.

Ablynx image

AbbVie signs $840m RA deal

September 25, 2013
Sales and Marketing AbbVie, Ablynx, RA, alx

News

Merck Serono eyes ‘Nanobody’ potential in rheumatology

October 14, 2010
Research and Development Ablynx, Merck Serono

Merck Serono has expanded its research with Ablynx and will co-develop ‘Nanobodies’ from the Belgian biotech against an inflammatory disease …

News

Boehringer selects lead candidate for Alzheimer’s

May 24, 2010
Research and Development Ablynx, Boehringer

Boehringer Ingelheim has selected a lead candidate for further development to treat Alzheimer’s disease from its collaboration with Ablynx. Belgium-based …

News

Next generation monoclonal antibodies to enter clinical trials in 2007

January 20, 2006
Research and Development Ablynx, Novartis

Novartis has signed a deal with Belgium biotech Ablynx to develop the next generation of monoclonal antibodies with clinical development …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026